A detailed history of Constitution Capital LLC transactions in Amgen Inc stock. As of the latest transaction made, Constitution Capital LLC holds 765 shares of AMGN stock, worth $209,158. This represents 0.13% of its overall portfolio holdings.

Number of Shares
765
Previous 765 -0.0%
Holding current value
$209,158
Previous $239,000 2.93%
% of portfolio
0.13%
Previous 0.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

BUY
$268.87 - $324.56 $205,685 - $248,288
765 New
765 $217,000
Q4 2022

Feb 09, 2023

BUY
$229.03 - $291.01 $198,110 - $251,723
865 New
865 $227,000
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $189,668 - $209,823
865 New
865 $209,000
Q4 2021

Feb 08, 2022

SELL
$198.88 - $227.6 $211,807 - $242,394
-1,065 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $226,067 - $264,865
1,065 New
1,065 $226,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Constitution Capital LLC Portfolio

Follow Constitution Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Constitution Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Constitution Capital LLC with notifications on news.